CPH
Physician Daily · Monday, August 24, 2026
Newsletters Sign in ON AIR
CrosspointHealthNEWS + REFERENCE LIBRARY
Diagnosis Sheet Obsessive-Compulsive and Related Disorders DSM-5-TR 312.39 | ICD-10-CM F63.3

Trichotillomania (Hair-Pulling Disorder)

Recurrent body-focused hair pulling producing noticeable hair loss, with repeated failed attempts to stop and heavy concealment.

Lifetime prevalence~1-2% of adults
Typical onsetAges 10-13, peripubertal
Sex ratio~4:1 to 10:1 female:male
CourseChronic, waxing and waning

Clinical picture

  • Scalp, eyebrows, and eyelashes are the most common sites, while pubic, facial, and body hair pulling is common but rarely disclosed.
  • Pulling occurs in an automatic mode outside awareness during sedentary activity and in a focused mode to relieve tension or a specific urge.
  • Many patients report tension before pulling and relief or gratification afterward, though a substantial subgroup describes no conscious urge.
  • Post-pulling rituals include inspecting the root, rolling the hair between the fingers, biting it, and swallowing it in 5-20% of patients.
  • Camouflage with hats, scarves, wigs, and makeup, plus avoidance of swimming, wind, and salons, marks the functional cost of the disorder.
  • Shame drives concealment, and many patients have never disclosed pulling to a clinician despite years of symptoms and dermatology visits.

Criteria snapshot

  • Recurrent pulling out of one's own hair resulting in hair loss, from any body site, occurring over time rather than in a single episode.
  • Repeated attempts to decrease or stop the pulling, which distinguishes the disorder from an untroubled and unproblematic habit.
  • Pulling causes clinically significant distress or impairment in social, occupational, or other important areas of functioning.
  • Not attributable to a dermatologic condition and not better explained by another mental disorder such as body dysmorphic disorder.
  • Tension before pulling and relief afterward are no longer required, which broadens the diagnosis to include purely automatic pullers.

Neurobiology

  • Best framed as a compulsivity and habit-learning disorder involving dorsal striatum, supplementary motor area, and weakened response inhibition.
  • Structural imaging shows volumetric changes in striatal and cortical motor regions along with reduced white matter integrity in habit pathways.
  • Glutamatergic modulation is supported by N-acetylcysteine 1200-2400 mg/day, which outperformed placebo in adults over 12 weeks.
  • Heritability is substantial, and SLITRK1 and SAPAP3 findings converge with knockout mouse models that display compulsive self-grooming.
  • Serotonergic agents show weak efficacy for pulling itself, distinguishing the disorder pharmacologically from OCD despite shared classification.
  • Trichobezoar from trichophagia can cause obstruction, perforation, and Rapunzel syndrome, requiring endoscopic or surgical removal.

Psychology

  • The behavioral model treats pulling as automatically reinforced by sensory stimulation and by relief from tension, boredom, or aversive affect.
  • Internal and external cues, such as sitting at a mirror, driving, reading, or feeling a coarse hair, reliably trigger discrete pulling episodes.
  • Emotion regulation accounts explain pulling as downregulation of boredom, anxiety, and frustration when other coping options feel unavailable.
  • Shame and concealment reduce help seeking and drive social avoidance, which in turn maintains isolation and lowers competing activity.
  • Perfectionism about hair symmetry or texture fuels focused pulling aimed at removing hairs judged coarse, gray, or otherwise imperfect.

Differential & comorbidity

  • Exclude alopecia areata, tinea capitis, and traction alopecia; dermoscopy in pulling shows broken hairs of varying lengths and no exclamation hairs.
  • Distinguish from OCD, where pulling would follow an obsession, and from BDD, where hair removal serves a specific appearance concern.
  • Excoriation disorder co-occurs in a substantial minority of patients, so screen for both body-focused repetitive behaviors together.
  • Comorbid major depression, anxiety disorders, and substance use are common and shape both engagement and treatment sequencing.
  • Ask about abdominal pain, vomiting, and early satiety whenever trichophagia is present, since trichobezoar can present as obstruction.

Pharmacologic treatment

  • No medication is FDA-approved; N-acetylcysteine 1200-2400 mg/day has the strongest adult evidence with a benign adverse effect profile.
  • SSRIs are largely ineffective for the pulling itself but remain appropriate for comorbid depression and anxiety disorders.
  • Clomipramine 100-250 mg/day shows modest benefit in small controlled trials; monitor ECG and anticholinergic burden closely.
  • Olanzapine 2.5-10 mg/day reduced symptoms in a controlled trial, but weigh metabolic and sedation risk against the modest benefit.
  • Pediatric N-acetylcysteine trials were negative, so behavior therapy remains the primary approach for children and younger adolescents.

Psychotherapy

  • Habit reversal training is first-line, combining awareness training, a competing response, and social support across 8-12 sessions.
  • Comprehensive behavioral treatment adds stimulus control and modality-specific strategies for automatic versus focused pulling patterns.
  • Acceptance-enhanced behavior therapy and DBT-informed skills improve maintenance by targeting affect regulation and urge tolerance.
  • Decoupling and stimulus-control tactics, including barriers, gloves, bandages, and fidget objects, reduce automatic episodes at known cue sites.
  • Behavior therapy effect sizes are large and clearly exceed medication, though relapse is common without scheduled booster sessions.

Adjunct options

  • Track with the Massachusetts General Hospital Hairpulling Scale or the NIMH Trichotillomania Severity Scale every 4-6 weeks.
  • Photograph affected areas with consent to document regrowth, which sustains motivation more reliably than patient self-report alone.
  • Coordinate with dermatology for scalp health and to definitively exclude alternative causes of patterned or diffuse alopecia.
  • TLC Foundation for BFRBs resources, peer support, and group treatment reduce shame and the isolation that maintains concealment.
  • Sleep regulation, stress reduction, and scheduled screen breaks lower cue exposure during high-risk sedentary evening periods.

Clinical pearls

  • Behavior therapy beats medication here; habit reversal is the treatment, not an add-on.
  • Ask whether they eat the hair; trichobezoar is a surgical problem waiting to happen.
  • Automatic pulling needs stimulus control; focused pulling needs a competing response.

References

  • American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.). https://doi.org/10.1176/appi.books.9780890425787
  • Franklin, M. E., & Tolin, D. F. (2007). Treating trichotillomania: Cognitive-behavioral therapy for hairpulling and related problems. Springer.
  • Grant, J. E., & Chamberlain, S. R. (2016). Trichotillomania. The American Journal of Psychiatry, 173(9), 868-874.
  • Grant, J. E., Odlaug, B. L., & Kim, S. W. (2009). N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: A double-blind, placebo-controlled study. Archives of General Psychiatry, 66(7), 756-763.
  • Sadock, B. J., Sadock, V. A., & Ruiz, P. (2021). Kaplan & Sadock's synopsis of psychiatry (12th ed.). Wolters Kluwer.
  • Stahl, S. M. (2021). Stahl's essential psychopharmacology (5th ed.). Cambridge University Press.
  • Woods, D. W., & Twohig, M. P. (2008). Trichotillomania: An ACT-enhanced behavior therapy approach therapist guide. Oxford University Press.